[BNTC] YoY Annual Result on 30-Jun-2022 [#FY]

Stock
[BNTC] Benitec Biopharma Inc.
Announcement Date
02-Sep-2022
Financial Year
2022
Quarter
30-Jun-2022 [#FY]
Profit Trend
YoY- -34.69%
Quarter Report
BNTC's Result
BNTC's Financial Summary
View:
Show?
Annual Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 216 75 73 59 97 11,317 455 -11.66%
PBT -22,370 -19,562 -18,208 -13,882 -8,274 2,867 -8,551 17.36%
Tax -619 3 354 -101 27 -864 1 -
NP -21,751 -19,562 -18,562 -13,781 -8,301 2,867 -8,551 16.81%
Tax Rate - - - - - 30.14% - -
Total Cost 21,967 19,637 18,635 13,840 8,398 8,450 9,006 16.00%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -10,069.91 -26,082.67 -25,427.40 -23,357.63 -8,557.73 25.34 -1,877.42 32.27%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -5.36 -14.12 -38.62 -54.54 -138.19 56.89 -207.21 -45.58%
EPS Diluted -5.36 -14.12 -38.62 -54.54 -138.19 56.89 -207.21 -45.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.